Ticker Details
Zentalis Pharmaceuticals, Inc.
IPO Date:	April 3, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$289.02M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.80 | 3.61%
Avg Daily Range (30 D):	$0.27 | 5.98%
Avg Daily Range (90 D):	$0.19 | 5.80%

Institutional Daily Volume
Avg Daily Volume:	.7M
Avg Daily Volume (30 D):	2.84M
Avg Daily Volume (90 D):	1.56M

Trade Size
Avg Trade Size (Sh.):	98
Avg Trade Size (Sh.) (30 D):	140
Avg Trade Size (Sh.) (90 D):	137

Institutional Trades
Total Institutional Trades:	1,930
Avg Institutional Trade:	$2.09M
Avg Institutional Trade (30 D):	$.68M
Avg Institutional Trade (90 D):	$.67M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.73M
Avg Closing Trade (30 D):	$.72M
Avg Closing Trade (90 D):	$.72M
Avg Closing Volume:	121.56K

News

May 1, 2026 @ 9:30 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Na

Apr 1, 2026 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Na

Jan 12, 2026 @ 3:35 PM Fast-Tracking the $537B Cancer Cure: How Accelerat... Source: Prnewswire

Dec 17, 2025 @ 2:00 PM Incyclix Bio Expands Board of Directors with Appoi... Source: Tony Plohoros

Sep 2, 2025 @ 9:00 PM Zentalis Pharmaceuticals Announces Inducement Gran... Source: Aron Feingold

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.73	$-.5	$-.49
Diluted EPS	$-1.73	$-.5	$-.49
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-124.13M	$-35.35M	$-35.22M
Operating Income / Loss	$-145.04M	$-37.86M	$-37.39M
Cost of Revenue
Net Cash Flow	$-10M	$-4.07M	$-3.08M
PE Ratio